Regular exercise should be part of cancer care for all patients

byEuropean Society for Medical OncologyQuality of life scores before and after chemotherapy in active and inactive patients. Credit: European Society for Medical OncologyIncluding exercise or sp

Updated on: December 18,2023

Regular exercise should be part of cancer care for all patients

byEuropean Society for Medical OncologyQuality of life scores before and after chemotherapy in active and inactive patients. Credit: European Society for Medical OncologyIncluding exercise or sp

Updated on:December 18,2023

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t

Updated on: December 18,2023

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t

Updated on:December 18,2023

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Updated on: February 01,2024

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Updated on:February 01,2024

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on: March 14,2024

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on:March 14,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024

New microfluidic device for cancer detection achieves precise separation of tumor entities

by TranSpreadSchematic illustration of high-throughput, continuous-flow ternary separation of tumor cells and clusters from WBCs in large volumes of pleural or abdominal effusions using our spiral-con

Updated on: April 28,2024

New microfluidic device for cancer detection achieves precise separation of tumor entities

by TranSpreadSchematic illustration of high-throughput, continuous-flow ternary separation of tumor cells and clusters from WBCs in large volumes of pleural or abdominal effusions using our spiral-con

Updated on:April 28,2024

New Method for Delivering Drugs to Lung Metastases: Algae-Based Biohybrid Microrobots

Updated on: June 21,2024

New Method for Delivering Drugs to Lung Metastases: Algae-Based Biohybrid Microrobots

Updated on:June 21,2024

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

Updated on: December 27,2023

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

Updated on:December 27,2023

Novel treatment shows promise against rare cancer in kids

by Carla K. JohnsonThis December 1993 microscope photo provided by the National Cancer Institute shows a typical neuroblastoma with rosette formation. In a study published Wednesday, April 5, 2023, in

Updated on: March 25,2024

Novel treatment shows promise against rare cancer in kids

by Carla K. JohnsonThis December 1993 microscope photo provided by the National Cancer Institute shows a typical neuroblastoma with rosette formation. In a study published Wednesday, April 5, 2023, in

Updated on:March 25,2024

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on: December 26,2023

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on:December 26,2023

High magnetic field reduces side effects caused by anti-cancer drug imatinib

by Zhang Nannan,Chinese Academy of Sciences9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Credit: Ji XinmiaoResearchers led by Prof. Zhang Xin

Updated on: December 22,2023

High magnetic field reduces side effects caused by anti-cancer drug imatinib

by Zhang Nannan,Chinese Academy of Sciences9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Credit: Ji XinmiaoResearchers led by Prof. Zhang Xin

Updated on:December 22,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on: December 22,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on:December 22,2023